Meeting
2019 Breakthrough
Plasma circulating tumor DNA-based genetic profiling of lung cancer patients in Vietnam using ultra-deep massive parallel sequencing with unique identifier tagging.
Authors
Huy Phuoc Do
Gene Solutions, Vietnam, Medical Genetics Institute, Ho Chi Minh, Viet Nam
Huy Phuoc Do , Thao Thanh Tran Nguyen , Uyen Vu Tran , Thanh-Truong Tran , Anh-Thu Huynh Dang , Vu Trieu Nguyen , Chu Van Nguyen , Han Ngoc Do , Minh-Duy Phan , Le Son Tran , Hoai-Nghia Nguyen , Hoa Giang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Access to Care, Diagnostics, Early Detection and Diagnosis, Prevention and Screening, and Surveillance
Track
Access to Care,Diagnostics,Early Detection and Diagnosis,Prevention and Screening,Surveillance
Sub Track
Early Detection and Diagnosis
Citation
J Glob Oncol 5, 2019 (suppl 1; abstr 58)
DOI
10.1200/JGO.2019.5.suppl.58
Abstract #
58
Poster Bd #
D12
Abstract Disclosures
Similar Posters
Poster
2019 Breakthrough
Mutation spectrum of major cancer driver genes in Vietnamese NSCLC patients.
First Author: Uyen Vu Tran
Poster
2023 ASCO Annual Meeting
Utility of ctDNA tumor fraction to inform negative liquid biopsy (LBx) results and need for tissue reflex in advanced non-small cell lung cancer (aNSCLC).
First Author: Christian Diego Rolfo
Poster
2023 ASCO Annual Meeting
LIBELULE: A randomized phase III study to evaluate the clinical relevance of early liquid biopsy (LB) in patients with suspicious metastatic lung cancer.
First Author: Aurélie Swalduz
Poster
2021 ASCO Annual Meeting
Driver mutations to predict for poorer outcomes in non-small cell lung cancer patients treated with concurrent chemoradiation and consolidation durvalumab.
First Author: Yufei Liu